Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Familial Partial Lipodystrophy: early-phase trial registry
1 of 3 indexed Familial Partial Lipodystrophy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Familial Partial Lipodystrophy: 3 US clinical trials tracked, 1 recruiting.
Familial Partial Lipodystrophy is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Abhimanyu Garg, running 1 of these trials.
Enrollment posture brief
Registry condition familial-partial-lipodystrophy
OPEN 1 | RECR 33% | LATE 1 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Familial Partial Lipodystrophy lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Familial Partial Lipodystrophy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Familial Partial Lipodystrophy is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Amryt Pharma
NCT06679270
Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients
Abhimanyu Garg
NCT02430077
Study of Gemcabene in Adults With FPLD
Elif Oral
NCT03508687
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Familial Partial Lipodystrophy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Familial Partial Lipodystrophy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Familial Partial Lipodystrophy page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Familial Partial Lipodystrophy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Abhimanyu Garg sponsors the most Familial Partial Lipodystrophy trials on record, review their full trial history before evaluating a specific study. See Abhimanyu Garg's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Familial Partial Lipodystrophy condition card totals 3 registered trials; most-linked intervention 600mg Gemcabene; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.